#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	3796	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2616	430.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1785	1785	C	538	C	460	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5910	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4077	434.3	0	.	n	.	0	T695C	SNP	695	695	T	1338	1338	C	418	C,A	345,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5910	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4077	434.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1980	1980	A	536	A,G	453,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5910	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4077	434.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2614	2614	C	520	C	440	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5910	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4077	434.3	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3240	3240	T	497	T	426	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5910	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4077	434.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2688	2688	A	559	A	483	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	582	folP	852	852	100.0	folP.l6.c17.ctg.1	1925	90.3	1	SNP	p	R228S	1	.	.	682	684	AGC	1221	1223	AGC	123;124;123	A;G;C,A,T	105;106;106,1,1	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1224	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3713	98.5	1	SNP	p	S91F	0	.	.	271	273	TCC	738	740	TCC	109;109;109	T;C;C,T	85;92;90,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1224	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3713	98.5	1	SNP	p	D95G	0	.	.	283	285	GAC	750	752	GAC	111;111;112	G;A;C	93;92;88	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1224	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3713	98.5	1	SNP	p	D95N	0	.	.	283	285	GAC	750	752	GAC	111;111;112	G;A;C	93;92;88	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	442	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1654	79.9	0	.	p	.	0	A39T	NONSYN	115	117	GCC	629	631	ACC	114;115;116	A;C;C,A	101;102;104,1	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	442	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1654	79.9	0	.	p	.	0	R44H	NONSYN	130	132	CGC	644	646	CAC	116;116;116	C;A;C	100;104;104	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	442	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1654	79.9	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	827	829	CAC	127;128;128	C;A;C	104;107;108	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	442	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1654	79.9	1	SNP	p	G45D	0	.	.	133	135	GGC	647	649	GGC	116;116;116	G;G;C	104;104;104	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	296	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1412	62.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1272	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3347	113.8	1	SNP	p	D86N	0	.	.	256	258	GAC	728	730	GAC	165;164;165	G;A,C;C	132;131,1;137	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1272	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3347	113.8	1	SNP	p	S87R	0	.	.	259	261	AGT	731	733	AGT	165;165;164	A;G;T	133;139;134	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1272	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3347	113.8	1	SNP	p	S87W	0	.	.	259	261	AGT	731	733	AGT	165;165;164	A;G;T	133;139;134	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1272	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3347	113.8	1	SNP	p	S87I	0	.	.	259	261	AGT	731	733	AGT	165;165;164	A;G;T	133;139;134	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1272	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3347	113.8	1	SNP	p	S88P	0	.	.	262	264	TCC	734	736	TCC	164;164;162	T;C;C	137;142;138	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	988	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2895	101.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1694	1696	GGC	128;126;126	G;G;C,A	113;112;109,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	898	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2688	99.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1395	1397	GCA	131;130;130	G;C;A,G	114;112;113,1	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	898	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2688	99.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1398	1400	ATC	130;130;130	A;T;C	112;109;112	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	898	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2688	99.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1410	1412	GTG	131;131;130	G;T;G,A	110;108;108,1	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	898	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2688	99.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1410	1412	GTG	131;131;130	G;T;G,A	110;108;108,1	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	898	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2688	99.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1914	1916	ACC	112;112;111	A;C,A;C	92;91,1;93	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	898	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2688	99.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1968	1970	GCG	118;118;117	G;C,T,G;G	93;87,1,1;87	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	898	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2688	99.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1968	1970	GCG	118;118;117	G;C,T,G;G	93;87,1,1;87	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	898	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2688	99.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2091	2093	GGC	108;108;108	G;G;C	93;93;98	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	898	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2688	99.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2100	2102	GGC	108;107;105	G;G;C	92;94;89	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	898	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2688	99.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2118	2120	CCG	109;110;109	C,A;C;G	91,1;90;90	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1142	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3615	94.6	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1889	1891	CTG	111;110;112	C;T;G	89;89;91	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	570	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2153	78.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	677	677	C	66	C	59	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	656	porB1b	1035	1035	95.64	porB1b.l15.c17.ctg.1	1747	109.0	0	.	p	.	0	F135L	NONSYN	403	405	TTT	695	697	CTT	139;138;138	C;T;T,A	116;113;110,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	656	porB1b	1035	1035	95.64	porB1b.l15.c17.ctg.1	1747	109.0	0	.	p	.	0	R143G	NONSYN	427	429	AGA	719	721	GGA	140;140;140	G;G;A	122;123;118	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	656	porB1b	1035	1035	95.64	porB1b.l15.c17.ctg.1	1747	109.0	0	.	p	.	0	D171G	NONSYN	511	513	GAT	803	805	GGT	130;130;131	G;G,C;T	110;107,1;112	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	656	porB1b	1035	1035	95.64	porB1b.l15.c17.ctg.1	1747	109.0	0	.	p	.	0	G189S	NONSYN	565	567	GGC	857	859	AGC	136;136;137	A;G;C	113;113;115	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	656	porB1b	1035	1035	95.64	porB1b.l15.c17.ctg.1	1747	109.0	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	923	923	T	128	T	112	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	656	porB1b	1035	1035	95.64	porB1b.l15.c17.ctg.1	1747	109.0	1	SNP	p	G120K	0	.	.	358	360	GGT	650	652	GGT	148;148;148	G;G;T	125;122;122	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	656	porB1b	1035	1035	95.64	porB1b.l15.c17.ctg.1	1747	109.0	1	SNP	p	A121D	0	.	.	361	363	GCC	653	655	GCC	147;147;146	G;C;C	121;115;125	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	656	porB1b	1035	1035	95.64	porB1b.l15.c17.ctg.1	1747	109.0	1	SNP	p	A121N	0	.	.	361	363	GCC	653	655	GCC	147;147;146	G;C;C	121;115;125	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2296	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5480	125.6	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2287	2289	AAT	143;143;143	A;A;T	128;126;125	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	408	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1552	78.8	1	SNP	p	V57M	1	.	.	169	171	ATG	750	752	ATG	171;172;170	A;T,C;G	140;142,1;137	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
